Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Metformin use in chronic kidne...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Metformin use in chronic kidney disease: new evidence to guide dosing.
Bibliographic Details
Main Authors:
Herrington, W
,
Nye, H
,
Aung, T
Format:
Journal article
Language:
English
Published:
2013
Holdings
Description
Similar Items
Staff View
Similar Items
Metformin: the safest hypoglycaemic agent in chronic kidney disease?
by: Nye, H, et al.
Published: (2011)
Conventional and genetic evidence on the association between adiposity and chronic kidney disease
by: Zhu, P, et al.
Published: (2020)
Empagliflozin and cardiovascular outcomes in patients with chronic kidney disease: the EMPA-KIDNEY trial
by: Preiss, D, et al.
Published: (2022)
Retarding Progression of Chronic Kidney Disease in Autosomal Dominant Polycystic Kidney Disease with Metformin and Other Therapies: An Update of New Insights
by: Carullo N, et al.
Published: (2021-09-01)
Metformin doses to ensure efficacy and safety in patients with reduced kidney function.
by: Isabelle H S Kuan, et al.
Published: (2021-01-01)